ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Best’s Special Report: US Publicly Traded Health Insurers Sustain Revenue Growth Trend in 2023; Margins Likely to be Pressured in 2024

Publicly traded U.S. health insurance companies saw another year of growth, as total GAAP revenue rose in 2023 by 10.4% to $1.07 trillion. However, according to a new AM Best report, future results may be pressured as the profitability of government programs returns to more normal levels.

The new Best’s Special Report, titled, “Revenue Grows but Margins Are Pressured for US Publicly Traded Health Insurers,” states that half of the 10 publicly traded health insurers followed for this report reported double-digit premium growth in 2023, led by Oscar Health, Inc., at 46.9%; the population in aggregate also saw a 28.5% increase in investment income. Net income grew to $45.3 billion, a 6.8% increase over 2022, following a 12.5% spike in the previous year.

“With medical costs continue to rise across the United States, insurers have been raising premium rates and are likely to continue doing so in 2024 to maintain favorable earnings,” said Kaitlin Piasecki, industry research analyst, AM Best.

According to the report, Medicare Advantage (MA) earnings are being pressured by the decline in reimbursement rates from Centers for Medicare & Medicaid Services and an increase in medical claims and utilization. Medicaid managed care business already has begun to see a drastic decline in enrollment, which could be accompanied by a worsening of the risk pool as eligibility redeterminations are completed.

“Overall earnings for companies solely operating government programs could be challenged in 2024, but these companies should remain profitable,” said Jason Hopper, associate director, industry research and analytics, AM Best. “Medical management of those with chronic conditions, as well as quality programs and related bonus payments, will be extremely important for sustained earnings for these health plans. For plans operating in all business segments, commercial business margins will become a greater focus given the likely earning declines in Medicare Advantage and Medicaid managed care.”

To access the full copy of this special report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=342355.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.